バイオマーカー検査サービスの世界市場規模調査・予測：製品別（バイオマーカーアッセイ開発、フローサイトメトリー、その他）、エンドユーザー別（製薬企業・バイオ企業、研究機関、CRO）、地域別分析、2022-2029年

バイオマーカー検査サービスの世界市場は、2021年に約7億5960万米ドルと評価され、予測期間2022-2029年には6.9%を超える健全な成長率で成長すると予測されています。

バイオマーカー検査サービスは、生物学的プロセスを測定するための強力なアプローチを与え、薬理学的介入に反応する正常な状態だけでなく、病的な状態においても指標として機能します。ヒトの病気を調査するために、医師は長年にわたり、血液やその他の体液中のDNAまたはタンパク質レベルでのバイオマーカー分析を使用してきました。がん、免疫反応、遺伝性疾患、心血管疾患などの臨床疾患は、医師がバイオマーカーサービスを利用して特定し、治療することが多い疾患です。バイオマーカー検査サービス市場は、がん検出のためのバイオマーカー検査の需要増加や研究開発活動の活発化などの要因によって拡大しています。

研究開発のため、新しいバイオマーカーが発見されています。例えば、2020年にsTNFR2が急性成人T細胞白血病/リンパ腫の診断のための新規バイオマーカーとして特定されました。これと同様に、2018年にはFDAがマラリア治療のためのPlasmodium 18S rRNA/rDNAバイオマーカーを承認しています。こうした発見や技術的な改善により、市場は予測期間中に収益性の高い成長を遂げると予測されます。この製品の発売が成功すれば、患者に代替の選択肢を提供できる可能性があります。さらに、臨床研究におけるバイオマーカーの需要の高まりと、バイオマーカー検査の需要を支える慢性疾患や感染症の負担の増大が、市場に有利な成長をもたらしています。しかし、バイオマーカー試験サービスの高コストとバイオマーカー開発のための高い資本投資と長いタイムラインは、2022年から2029年の予測期間を通じて市場成長を阻害します。

バイオマーカー検査サービスの世界市場調査において考慮される主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米は、主要な市場プレイヤーの存在感の高まり、ラボ診断テストの増加、生活習慣病の流行などの要因から、市場シェアを独占しています。CDCは、2020年には北米で約3,730万人の糖尿病患者が発生すると予測しており、そのうち2,870万人が診断済み、850万人が未診断であるとしています。老年人口と対象人口の増加、バイオシミラー開発のための共同研究の増加、主要企業の地理的拡大、政府機関や非営利団体による市場空間への積極的な参加は、予測期間中にアジア太平洋地域で大きな成長が見込まれる要因のほんの一部にすぎません。

本調査の目的は、近年におけるさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • バイオマーカー検査サービス市場：地域別、2019年～2029年
  • バイオマーカー検査サービス市場：製品別、2019年～2029年
  • バイオマーカー検査サービス市場：エンドユーザー別、2019年～2029年
• 主な動向
• 調査手法
• 調査前提条件

第2章 バイオマーカー検査サービスの世界市場定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 世界のバイオマーカー検査サービス市場力学

• バイオマーカー検査サービス市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • がん検出のためのバイオマーカー検査需要の増加
    • 研究開発活動の増加
  • 市場の課題
    • バイオマーカー検査サービスの高コスト
    • バイオマーカー開発のための高い資本投資と長いタイムライン
  • 市場機会
    • 慢性疾患や感染症の負担増がバイオマーカー検査の需要を支える

第4章 世界のバイオマーカー検査サービス市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• 投資採用モデル
• アナリストの結論・提言
• トップ投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 バイオマーカー検査サービスの世界市場：製品別

• 市場スナップショット
• バイオマーカー検査サービスの世界市場：製品別、性能-ポテンシャル分析
• バイオマーカー検査サービスの世界市場、製品別推定・予測2019～2029年
• バイオマーカー検査サービス市場、サブセグメント分析
  • バイオマーカーアッセイ開発
  • フローサイトメトリー
  • その他

第7章：バイオマーカー検査サービスの世界市場、エンドユーザー別

• 市場スナップショット
• バイオマーカー検査サービスの世界市場：エンドユーザー別実績-ポテンシャル分析
• バイオマーカー検査サービスの世界市場、エンドユーザー別推定・予測2019-2029
• バイオマーカー検査サービス市場、サブセグメント分析
  • 製薬会社、バイオテクノロジー企業
  • 調査機関
  • CRO

第8章 バイオマーカー検査サービスの世界市場：地域別分析

• バイオマーカー検査サービス市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品別の推定・予測、2019-2029年
    • エンドユーザー別の推定・予測、2019年～2029年
  • カナダ
• 欧州バイオマーカー検査サービス市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域のバイオマーカー検査サービス市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのバイオマーカー検査サービス市場スナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第9章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Bio Agilytix Labs
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Euro fins Scientific
  • SGS SA
  • Charles River Laboratories
  • Labcorp Drug Development
  • Thermo Fisher Scientific Inc.（PPD, Inc.）
  • ICON Plc
  • IQVIA
  • Syneos Health
  • Intertek Group Plc

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Biomarker Testing Services Market, report scope
• TABLE 2. Global Biomarker Testing Services Market estimates & forecasts by Region 2019-2029 (USD Million)
• TABLE 3. Global Biomarker Testing Services Market estimates & forecasts by Product 2019-2029 (USD Million)
• TABLE 4. Global Biomarker Testing Services Market estimates & forecasts by End User 2019-2029 (USD Million)
• TABLE 5. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 6. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 7. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 8. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 9. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 10. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 11. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 12. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 13. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 14. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 15. U.S. Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 16. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 17. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 18. Canada Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 19. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 20. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 21. UK Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 22. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 23. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 24. Germany Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 25. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 26. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 27. France Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 28. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 29. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 30. Italy Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 31. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 32. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 33. Spain Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 34. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 35. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 36. RoE Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 37. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 38. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 39. China Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 40. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 41. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 42. India Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 43. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 44. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 45. Japan Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 46. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 47. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 48. South Korea Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 49. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 50. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 51. Australia Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 52. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 53. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 54. RoAPAC Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 55. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 56. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 57. Brazil Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 58. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 59. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 60. Mexico Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 61. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 62. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 63. RoLA Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 64. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 65. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 66. Row Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 67. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 68. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 69. List of secondary sources, used in the study of global Biomarker Testing Services Market
• TABLE 70. List of primary sources, used in the study of global Biomarker Testing Services Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Biomarker Testing Services Market, research methodology
• FIG 2. Global Biomarker Testing Services Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Biomarker Testing Services Market, key trends 2021
• FIG 5. Global Biomarker Testing Services Market, growth prospects 2022-2029
• FIG 6. Global Biomarker Testing Services Market, porters 5 force model
• FIG 7. Global Biomarker Testing Services Market, pest analysis
• FIG 8. Global Biomarker Testing Services Market, value chain analysis
• FIG 9. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 10. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 11. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 12. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 13. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 14. Global Biomarker Testing Services Market, regional snapshot 2019 & 2029
• FIG 15. North America Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 16. Europe Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 17. Asia pacific Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 18. Latin America Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 19. Global Biomarker Testing Services Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Biomarker Testing Services Market is valued at approximately USD 759.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2022-2029. Biomarker testing services give a powerful approach to measuring a biological process and act as an indicator in normal as well as pathological conditions in response to pharmacological intervention. To research human diseases, doctors have used biomarker analysis in blood or other body fluids at the DNA or protein level for many years. Clinical illnesses such as cancer, immunological responses, genetic disorders, and cardiovascular diseases are among the conditions that doctors frequently use biomarker services to identify and treat. The Biomarker Testing Services market is expanding because of factors such as increasing demand for biomarker testing for cancer detection and increasing R&D activities.

New biomarkers are being discovered because of research and development. For instance, sTNFR2 was identified as a novel biomarker for the diagnosis of acute adult T-cell leukemia/lymphoma in 2020. Similar to this, in 2018 the FDA approved the Plasmodium 18S rRNA/rDNA biomarker for the treatment of malaria. Due to these discoveries and technical improvements, the market is predicted to grow profitably during the forecast period. The successful launch of this product may provide patients with an alternative option. Furthermore, the growing demand for biomarkers in clinical studies and the growing burden of chronic and infectious diseases supporting demand for biomarker testing is creating lucrative growth in the market. However, the high cost of biomarker testing services and high capital investments and lengthy timelines for biomarker development stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biomarker Testing Services Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market share owing to factors such as the rising presence of key market players, increase in laboratory diagnostic testing, and prevalence of lifestyle diseases. In 2020, the CDC projects that there may be about 37.3 million diabetes in the country, including 28.7 million cases that have been diagnosed and 8.5 million that have not. A growing geriatric and target population, an increase in the number of collaborations for biosimilar development, the geographic expansion of key players, and active participation by government and nonprofit organisations in the market space are just a few of the factors driving Asia Pacific's expected significant growth during the forecast period.

Major market players included in this report are:

Bio Agilytix Labs

Eurofins Scientific

SGS SA

Charles River Laboratories

Labcorp Drug Development

Thermo Fisher Scientific Inc. (PPD, Inc.)

ICON Plc

IQVIA

Syneos Health

Intertek Group Plc

Recent Developments in the Market:

• In April2021, Amgen announced the launch of Biomarker AssistTM, a programme to make biomarker testing more accessible to patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker AssistTM.
• In February 2022, oncodna introduced the launch of the oncodeep kit. a complete workflow solution is provided by the kit, permitting laboratories with ngs capabilities to perform comprehensive biomarker testing, provide powerful data analysis, and support oncologists in the most effective and personalized treatments for their cancer patients. For the quick analysis and reporting of a patient's tumor molecular profile, the offer will come in combination with oncodna's data analysis and clinical interpretation tools.

Global Biomarker Testing Services Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, End User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Biomarker Assay Development

Flow Cytometry

Others

By End User:

Pharmaceutical and biotechnology companies

Research Institutes

CRO

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Biomarker Testing Services Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Biomarker Testing Services Market, by Product, 2019-2029 (USD Million)
  • 1.2.3. Biomarker Testing Services Market, by End User, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Biomarker Testing Services Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Biomarker Testing Services Market Dynamics

• 3.1. Biomarker Testing Services Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing demand for biomarker testing for cancer detection
    • 3.1.1.2. Increasing R&D activities
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Biomarker Testing Services
    • 3.1.2.2. High capital investments and lengthy timelines for biomarker development
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing burden of chronic and infectious diseases supporting demand for biomarker testing

Chapter 4. Global Biomarker Testing Services Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biomarker Testing Services Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Biomarker Testing Services Market by Product, Performance - Potential Analysis
• 6.3. Global Biomarker Testing Services Market Estimates & Forecasts by Product 2019-2029 (USD Million)
• 6.4. Biomarker Testing Services Market, Sub Segment Analysis
  • 6.4.1. Biomarker Assay Development
  • 6.4.2. Flow Cytometry
  • 6.4.3. Others

Chapter 7. Global Biomarker Testing Services Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Biomarker Testing Services Market by End User, Performance - Potential Analysis
• 7.3. Global Biomarker Testing Services Market Estimates & Forecasts by End User 2019-2029 (USD Million)
• 7.4. Biomarker Testing Services Market, Sub Segment Analysis
  • 7.4.1. Pharmaceutical and biotechnology companies
  • 7.4.2. Research Institutes
  • 7.4.3. CRO

Chapter 8. Global Biomarker Testing Services Market, Regional Analysis

• 8.1. Biomarker Testing Services Market, Regional Market Snapshot
• 8.2. North America Biomarker Testing Services Market
  • 8.2.1. U.S. Biomarker Testing Services Market
    • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Biomarker Testing Services Market
• 8.3. Europe Biomarker Testing Services Market Snapshot
  • 8.3.1. U.K. Biomarker Testing Services Market
  • 8.3.2. Germany Biomarker Testing Services Market
  • 8.3.3. France Biomarker Testing Services Market
  • 8.3.4. Spain Biomarker Testing Services Market
  • 8.3.5. Italy Biomarker Testing Services Market
  • 8.3.6. Rest of Europe Biomarker Testing Services Market
• 8.4. Asia-Pacific Biomarker Testing Services Market Snapshot
  • 8.4.1. China Biomarker Testing Services Market
  • 8.4.2. India Biomarker Testing Services Market
  • 8.4.3. Japan Biomarker Testing Services Market
  • 8.4.4. Australia Biomarker Testing Services Market
  • 8.4.5. South Korea Biomarker Testing Services Market
  • 8.4.6. Rest of Asia Pacific Biomarker Testing Services Market
• 8.5. Latin America Biomarker Testing Services Market Snapshot
  • 8.5.1. Brazil Biomarker Testing Services Market
  • 8.5.2. Mexico Biomarker Testing Services Market
• 8.6. Rest of The World Biomarker Testing Services Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Bio Agilytix Labs
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Euro fins Scientific
  • 9.2.3. SGS SA
  • 9.2.4. Charles River Laboratories
  • 9.2.5. Labcorp Drug Development
  • 9.2.6. Thermo Fisher Scientific Inc. (PPD, Inc.)
  • 9.2.7. ICON Plc
  • 9.2.8. IQVIA
  • 9.2.9. Syneos Health
  • 9.2.10. Intertek Group Plc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption